Hospital/Health-System Pharmacy

The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower MortalityA study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Six Ways to Support Diabetic Patients with Their Treatment Plans
Six Ways to Support Diabetic Patients with Their Treatment PlansHere are six ways providers can help patients manage this daunting disease.
Readmission Cost Savings are a Reality with Enhanced Patient EngagementReduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.
Are Virtual Agents Ready to Interact with Your Healthcare Consumers?Eye-opening research by NTT DATA Services sheds light on healthcare consumer satisfaction with virtual versus human agents.
How Current Accreditation Approaches Impact Reduction of Hospital ReadmissionsHospitals are always looking for ways to reduce readmission rates. They may have an unusual ally in a quality control system originally developed in Europe for the manufacturing sector. Read more about it.
How Healthcare Spin-Offs are Affecting the IndustryJohn R. Washlick, Buchanan, Ingersoll & Rooney, and expert in healthcare system transactions and market consolidation, talks to Managed Healthcare Executive about healthcare spin-offs, what that means for the future of mergers and acquisitions, and advice for healthcare executives.
Three Ways Healthcare Organizations Can Improve Care ManagementHere are three strategies to navigate toward next-generation care management and increase member engagement in the process
Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
How the Flu’s Severity Will Affect Healthcare SpendingThe flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy ChangesHow are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.